3 terminated, 1 withdrawn. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Terminated 3, Withdrawn 1 |
Follow Sulodexide: new trials by email Literature Review of Sulodexide trials Research Report on Sulodexide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Endothelial Protection in Convalescent COVID-19 Patients Sulodexide - Endothelial Dysfunction, Inflammation | Phase 4 | Terminated | Pirogov Russian National Research Medical University | 2 | 2022-04-01 | 2025-06-13 |
| Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation (ROTATE-2) Linagliptin, Empagliflozin, Telmisartan - Diabetic Nephropathy Type 2 | Phase 4 | Withdrawn | Steno Diabetes Center Copenhagen | 2017-11-15 | 2018-09-14 | |
| Prospective Evaluation of the QoL of Patients With PTS Who Receive Compression Therapy and Sulodexide Sulodexide, Compression therapy - Post-thrombotic Syndrome | Phase 4 | Terminated | Bama GeVe, S.L.U. | 13 | 2015-09-01 | 2017-08-31 |
| Effect of Sulodexide in Overt Diabetic Nephropathy Sulodexide, Placebo - Diabetic Nephropathy | Phase 4 | Terminated | Keryx Biopharmaceuticals | 968 | 2005-08-01 | 2021-03-19 |
COVID-19 (1) · Diabetes Mellitus (1) · Diabetic Nephropathies (1) · Inflammation (1) · Postthrombotic Syndrome (1) · Proteinuria (1) · Thrombosis (1)
Bama GeVe, S.L.U. (1) · Keryx Biopharmaceuticals (1) · Pirogov Russian National Research Medical University (1) · Steno Diabetes Center Copenhagen (1)
Australia (1) · Denmark (1) · Netherlands (1) · Russia (1) · Spain (1) · United States (1)
Edmund J Lewis, MD (1) · Itamar Raz, M.D. (1) · Josep Marinel.lo (1) · Kirill Lobastov, PhD (1) · Robert C Atkins, M.D. (1)